RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 56-66
  • Abbott to buy Russian drug maker

    Abbott to buy Russian drug maker
    Abbott Laboratories said Monday it has agreed to acquire a Russian pharmaceutical manufacturer for between $395 million and $495 million in cash plus the assumption of about $136 million in debt. The Lake County-based medical products company will...
  • AbbVie's $46 billion bid for Irish rival rejected

    Irish pharmaceutical company Shire Plc said Friday it had rejected a $46.3 billion takeover offer from North Chicago-based AbbVie Inc., thwarting, at least for now, the company’s attempt to tap into the London-listed company’s low tax rate....
  • U.S. regulator approves Afrezza inhalable insulin

    U.S. regulator approves Afrezza inhalable insulin
    After more than a decade of work and nearly $1 billion of his personal fortune, Los Angeles inventor Alfred Mann's quest to develop an inhalable form of insulin for people with diabetes won approval Friday from U.S. regulators. His company, MannKind...
  • U.S. senators seek review of proposed Valeant buyout of Allergan

    Seven U.S. senators have asked the Justice Department and Federal Trade Commission to review the proposed acquisition of Botox maker Allergan Inc. by a Canadian company, saying the deal could increase consumer pricing and curtail the development of new...
  • Illinois among 45 states settling off-label dispute with GlaxoSmithKline

    Illinois among 45 states settling off-label dispute with GlaxoSmithKline
    The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....
  • AbbVie takes fight for Irish drugmaker to shareholders

    AbbVie Inc. on Wednesday took its fight for control of the Irish drugmaker Shire Plc directly to shareholders, calling for immediate talks for a transaction it views as "highly executable." The North Chicago-based pharmaceutical firm, know for its...
  • Report: 'Doctor shopping' has declined in Virginia

     Report: 'Doctor shopping' has declined in Virginia
    "Doctor shopping" for illicit prescription drugs by Virginia residents showed a 73 percent decline from 2012 to 2013, according to data released this week by the Virginia Prescription Monitoring Program. The online program allows registered users...
  • MannKind shares rise 10% after insulin drug Afrezza OKd by FDA

    MannKind Corp., the Valencia company that last week won approval to market an inhalable form of insulin to people with diabetes, saw its shares climb 10% on Monday. The Food and Drug Administration announced Friday that it had approved MannKind's drug,...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • The Kid's Doctor: Thriving anti-vaccine movement sends an alarming message

    It seems the "anti-vaccine" movement is still alive and well and has become a hot topic on Twitter and Facebook again. Unfortunately, much of what I've read on these sites seems to be inaccurate and based on a lot of emotion and very little science....
  • Mildly low level of testosterone typically doesn't require treatment

    DEAR MAYO CLINIC: I'm a 52-year-old man. I recently had blood work done that showed my testosterone levels are slightly low, falling just below the "normal" range. Should I talk to my doctor about getting treatment even if I don't have any symptoms?...